Holmusk USA
Latest round
- Series B
Last raised
- Jan 2023
Total raised
- $80M
Investors
- 9
About Holmusk USA
Holmusk USA, Inc., founded in 2015, is headquartered in New York, US. The company focuses on behavioral health analytics, utilizing their flagship NeuroBlu Database to support clinical research.Holmusk offers data-driven solutions primarily through its NeuroBlu Database and NeuroBlu Analytics, which comprise a repository of clinical data for over 1 million patients. These tools empower healthcare researchers and providers to perform detailed analyses on various behavioral health conditions, including substance use disorders, major depressive disorder, and bipolar disorder.10.On October 2, 2023, Holmusk USA, Inc. The company aims to enhance its offerings and possibly explore new market expansions, although specific geographic targets have not been disclosed.
Who invested in Holmusk USA
9 investors across 4 rounds
See all investors in Holmusk USA
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Holmusk USA
Who invested in Holmusk USA?
Holmusk USA has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Holmusk USA raised?
Holmusk USA has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Holmusk USA last raise money?
Holmusk USA's most recent round on record is a Series B, in Jan 2023.
What does Holmusk USA do?
Holmusk USA is a healthcare it company.
Where is Holmusk USA headquartered?
Holmusk USA is headquartered in New York, US.
Which VCs invest in companies like Holmusk USA?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Holmusk USA's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like Holmusk USA? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.